Published in Br J Pharmacol on February 01, 1972
β-phenylethylamine, a small molecule with a large impact. Webmedcentral (2013) 0.77
Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol (1971) 3.82
The histochemical demonstration of monoamine oxidase activity by tetrazolium salts. J Histochem Cytochem (1957) 3.61
Metal-dependent aggregation of biogenic amines: a hypothesis for their storage and release. Nature (1969) 1.31
Pharmaceutical aspects of reserpine. J Am Pharm Assoc Am Pharm Assoc (1956) 1.03
Studies on the hypertensive response elicited by reserpine or tetrabenazine in rats treated with amphetamine-like drugs. Eur J Pharmacol (1968) 0.83
A comparison of the blood pressure effects of reserpine in dogs pretreated with amphetamine or tyramine. Arch Int Pharmacodyn Ther (1966) 0.83
Interactions between amphetamine and reserpine in vitro. Experientia (1969) 0.83
The pharmacology of benoxaprofen (2-[4-chlorophenyl]-alpha-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J Pharm Pharmacol (1977) 1.71
Relation between plasma concentration and therapeutic efficacy of a new anti-inflammatory compound, benoxaprofen (LRCL 3794) in rats with adjuvant-induced arthritis. J Pharm Pharmacol (1977) 0.94
An investigation of the effect of anti-inflammatory and anti-rheumatoid drugs in cell-mediated immune arthritis in guinea-pigs by microfocal radiography. Br J Exp Pathol (1980) 0.88
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine. Br J Pharmacol (1973) 0.87
Automated quantification of rat plasma acute phase reactants in experimental inflammation. J Pharmacol Methods (1989) 0.86
An assessment of the delayed hypersensitivity reaction to methylated bovine serum albumin in the mouse and its use in the evaluation of drug effects on cell mediated immune reactions. Agents Actions (1979) 0.85
Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug. J Pharmacol Exp Ther (1990) 0.84
Potential antiinflammatory compounds. 3. Compounds derived from acenaphthene and indan. J Med Chem (1979) 0.83
Some aspects of monoamine function in the earthworm (Lumbricus terrestris). Neuropharmacology (1975) 0.79
The assay of anti-pyretic drugs in mice, using intracerebral injection of pyretogenins. Br J Pharmacol (1968) 0.77
The induction of an erosive arthropathy in the guinea pig with copper II bisglycinate and its treatment with antirheumatic drugs. Br J Rheumatol (1987) 0.76
Evaluation of hypervitaminosis A in the rat by measurement of tibial bone breaking strain. J Pharmacol Methods (1984) 0.76
Pharmacological and biochemical activities of tenoxicam (Ro 12-0068), a new non-steroidal anti-inflammatory drug. Agents Actions (1984) 0.75
Prostaglandin E2 and collagenase release by cultured talus from type II collagen arthritis rats. Agents Actions (1986) 0.75
Substituted anilinopyridine carboxylic acids with antiinflammatory activity. J Med Chem (1967) 0.75
An injection block for small animals. Lab Pract (1972) 0.75
Synthesis and anticholinergic properties of 1-Adamant-1-yl-1-phenyl-3-N-pyrrolidino-1-propanol hydrochloride. J Med Chem (1972) 0.75
The use of intracerebral pyretogenins in testing for antipyretic activity in conscious mice. Br J Pharmacol (1968) 0.75
Romazarit: a potential disease-modifying antirheumatic drug. J Med Chem (1991) 0.75
The development of screening tests for D-penicillamine-like antirheumatic activity based on in vivo interactions with copper. Br J Rheumatol (1985) 0.75